Begic Zijo, Pandur Sanko, Omerbasic Edo, Kadic Almira, Halimic Mirza
Pediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Heart Center, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Mater Sociomed. 2017 Mar;29(1):73-75. doi: 10.5455/msm.2017.29.73-75.
Modern pediatric cardiology mainly deals with congenital heart defects (CHD), as the most common congenital anomalies. In most cases CHD requires surgical or interventional treatment.
The goal of the research was to evaluate CHD treatment at Pediatric Clinic, University Clinical Center (UCC) Sarajevo, Bosnia and Herzegovina (B&H). UCC Sarajevo is the only institution in B&H where cardiac treatment of CHD in pediatric population is performed. Pediatric cardiosurgery has started to develop in Bosnia and Herzegovina in April 1997.
Study included 745 patients (period from April 1997 to January 2017).
Cardiac treatment was performed on 745 patients with CHD, 541 (72.6%) of them were acyanotic patients and 204 (27.4%) were cyanotic patients. Reoperation was performed in 49 (6.5%) of patients. Out of total number of patients, 59 (7.9%) died. In 660 children (88.5%) a complete correction and in 85 (11.5%) a palliative operation/correction was performed. Defects with left to right shunt were present in 397 (53.2%) patients, complex heart defects with Tetralogy of Fallot in 173 (23.2%), obstructive heart defects in 106 (14.2%), obstructive heart defects with shunt in 53 (7.1%), and others in 16 (2.1%) of patients. During surgery, extracorporeal circulation was regulated in 554 (74.3%) patients. Peri and early postoperative complications occurred in 180 (24.1%) of patients. During this period 24 pacemakers were implanted and 24 radiofrequency ablations were performed.
Results of CHD cardiac treatment in childhood, which took place simultaneously, followed by the contractual joint programs and individual work of the Bosnian and Herzegovinian team has reached the highest level in the last two years, not only by the number, type and complexity of corrected CHD, but also by the age and body weight of the patients who underwent surgery, and development of invasive procedures, arrhytmology, pacemaker placement, intensive peri and postoperative treatment. That led pediatric cardiac surgery of UCC Sarajevo, to a position of leading center in the region.
现代小儿心脏病学主要处理先天性心脏病(CHD),这是最常见的先天性畸形。在大多数情况下,先天性心脏病需要手术或介入治疗。
本研究的目的是评估波斯尼亚和黑塞哥维那(波黑)萨拉热窝大学临床中心儿科诊所对先天性心脏病的治疗情况。萨拉热窝大学临床中心是波黑唯一一家对儿科患者进行先天性心脏病心脏治疗的机构。小儿心脏外科于1997年4月在波斯尼亚和黑塞哥维那开始发展。
研究纳入了745例患者(1997年4月至2017年1月期间)。
对745例先天性心脏病患者进行了心脏治疗,其中541例(72.6%)为非紫绀型患者,204例(27.4%)为紫绀型患者。49例(6.5%)患者进行了再次手术。在所有患者中,59例(7.9%)死亡。660例儿童(88.5%)接受了完全矫正,85例(11.5%)接受了姑息性手术/矫正。397例(53.2%)患者存在左向右分流缺陷,173例(23.2%)为法洛四联症等复杂心脏缺陷,106例(14.2%)为梗阻性心脏缺陷,53例(7.1%)为伴有分流的梗阻性心脏缺陷,16例(2.1%)为其他类型缺陷。手术期间,554例(74.3%)患者进行了体外循环。180例(24.1%)患者发生围手术期和术后早期并发症。在此期间,植入了24个起搏器并进行了24次射频消融。
过去两年中,波斯尼亚和黑塞哥维那团队通过合同联合项目及个人工作,同步开展的儿童先天性心脏病心脏治疗结果达到了最高水平,不仅体现在矫正的先天性心脏病的数量、类型和复杂性上,还体现在接受手术患者的年龄和体重以及侵入性手术、心律失常学、起搏器植入、围手术期和术后强化治疗的发展上。这使萨拉热窝大学临床中心的小儿心脏外科在该地区处于领先中心的地位。